520 related articles for article (PubMed ID: 29056226)
1. A Dementia-Associated Risk Variant near TMEM106B Alters Chromatin Architecture and Gene Expression.
Gallagher MD; Posavi M; Huang P; Unger TL; Berlyand Y; Gruenewald AL; Chesi A; Manduchi E; Wells AD; Grant SFA; Blobel GA; Brown CD; Chen-Plotkin AS
Am J Hum Genet; 2017 Nov; 101(5):643-663. PubMed ID: 29056226
[TBL] [Abstract][Full Text] [Related]
2. TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort.
van der Zee J; Van Langenhove T; Kleinberger G; Sleegers K; Engelborghs S; Vandenberghe R; Santens P; Van den Broeck M; Joris G; Brys J; Mattheijssens M; Peeters K; Cras P; De Deyn PP; Cruts M; Van Broeckhoven C
Brain; 2011 Mar; 134(Pt 3):808-15. PubMed ID: 21354975
[TBL] [Abstract][Full Text] [Related]
3. TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways.
Chen-Plotkin AS; Unger TL; Gallagher MD; Bill E; Kwong LK; Volpicelli-Daley L; Busch JI; Akle S; Grossman M; Van Deerlin V; Trojanowski JQ; Lee VM
J Neurosci; 2012 Aug; 32(33):11213-27. PubMed ID: 22895706
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of the frontotemporal dementia risk factor TMEM106B causes C9orf72-dependent alterations in lysosomes.
Busch JI; Unger TL; Jain N; Tyler Skrinak R; Charan RA; Chen-Plotkin AS
Hum Mol Genet; 2016 Jul; 25(13):2681-2697. PubMed ID: 27126638
[TBL] [Abstract][Full Text] [Related]
5. Elevated TMEM106B levels exaggerate lipofuscin accumulation and lysosomal dysfunction in aged mice with progranulin deficiency.
Zhou X; Sun L; Brady OA; Murphy KA; Hu F
Acta Neuropathol Commun; 2017 Jan; 5(1):9. PubMed ID: 28126008
[TBL] [Abstract][Full Text] [Related]
6. rs1990622 variant associates with Alzheimer's disease and regulates TMEM106B expression in human brain tissues.
Hu Y; Sun JY; Zhang Y; Zhang H; Gao S; Wang T; Han Z; Wang L; Sun BL; Liu G
BMC Med; 2021 Jan; 19(1):11. PubMed ID: 33461566
[TBL] [Abstract][Full Text] [Related]
7. TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia.
Nicholson AM; Finch NA; Wojtas A; Baker MC; Perkerson RB; Castanedes-Casey M; Rousseau L; Benussi L; Binetti G; Ghidoni R; Hsiung GY; Mackenzie IR; Finger E; Boeve BF; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Rademakers R
J Neurochem; 2013 Sep; 126(6):781-91. PubMed ID: 23742080
[TBL] [Abstract][Full Text] [Related]
8. TMEM106B haplotypes have distinct gene expression patterns in aged brain.
Ren Y; van Blitterswijk M; Allen M; Carrasquillo MM; Reddy JS; Wang X; Beach TG; Dickson DW; Ertekin-Taner N; Asmann YW; Rademakers R
Mol Neurodegener; 2018 Jul; 13(1):35. PubMed ID: 29970152
[TBL] [Abstract][Full Text] [Related]
9. TMEM106B a novel risk factor for frontotemporal lobar degeneration.
van der Zee J; Van Broeckhoven C
J Mol Neurosci; 2011 Nov; 45(3):516-21. PubMed ID: 21614538
[TBL] [Abstract][Full Text] [Related]
10. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions.
Van Deerlin VM; Sleiman PM; Martinez-Lage M; Chen-Plotkin A; Wang LS; Graff-Radford NR; Dickson DW; Rademakers R; Boeve BF; Grossman M; Arnold SE; Mann DM; Pickering-Brown SM; Seelaar H; Heutink P; van Swieten JC; Murrell JR; Ghetti B; Spina S; Grafman J; Hodges J; Spillantini MG; Gilman S; Lieberman AP; Kaye JA; Woltjer RL; Bigio EH; Mesulam M; Al-Sarraj S; Troakes C; Rosenberg RN; White CL; Ferrer I; Lladó A; Neumann M; Kretzschmar HA; Hulette CM; Welsh-Bohmer KA; Miller BL; Alzualde A; Lopez de Munain A; McKee AC; Gearing M; Levey AI; Lah JJ; Hardy J; Rohrer JD; Lashley T; Mackenzie IR; Feldman HH; Hamilton RL; Dekosky ST; van der Zee J; Kumar-Singh S; Van Broeckhoven C; Mayeux R; Vonsattel JP; Troncoso JC; Kril JJ; Kwok JB; Halliday GM; Bird TD; Ince PG; Shaw PJ; Cairns NJ; Morris JC; McLean CA; DeCarli C; Ellis WG; Freeman SH; Frosch MP; Growdon JH; Perl DP; Sano M; Bennett DA; Schneider JA; Beach TG; Reiman EM; Woodruff BK; Cummings J; Vinters HV; Miller CA; Chui HC; Alafuzoff I; Hartikainen P; Seilhean D; Galasko D; Masliah E; Cotman CW; Tuñón MT; Martínez MC; Munoz DG; Carroll SL; Marson D; Riederer PF; Bogdanovic N; Schellenberg GD; Hakonarson H; Trojanowski JQ; Lee VM
Nat Genet; 2010 Mar; 42(3):234-9. PubMed ID: 20154673
[TBL] [Abstract][Full Text] [Related]
11. Membrane orientation and subcellular localization of transmembrane protein 106B (TMEM106B), a major risk factor for frontotemporal lobar degeneration.
Lang CM; Fellerer K; Schwenk BM; Kuhn PH; Kremmer E; Edbauer D; Capell A; Haass C
J Biol Chem; 2012 Jun; 287(23):19355-65. PubMed ID: 22511793
[TBL] [Abstract][Full Text] [Related]
12. The TMEM106B FTLD-protective variant, rs1990621, is also associated with increased neuronal proportion.
Li Z; Farias FHG; Dube U; Del-Aguila JL; Mihindukulasuriya KA; Fernandez MV; Ibanez L; Budde JP; Wang F; Lake AM; Deming Y; Perez J; Yang C; Bahena JA; Qin W; Bradley JL; Davenport R; Bergmann K; Morris JC; Perrin RJ; Benitez BA; Dougherty JD; Harari O; Cruchaga C
Acta Neuropathol; 2020 Jan; 139(1):45-61. PubMed ID: 31456032
[TBL] [Abstract][Full Text] [Related]
13. TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III.
Jun MH; Han JH; Lee YK; Jang DJ; Kaang BK; Lee JA
Mol Brain; 2015 Dec; 8():85. PubMed ID: 26651479
[TBL] [Abstract][Full Text] [Related]
14. A novel temporal-predominant neuro-astroglial tauopathy associated with TMEM106B gene polymorphism in FTLD/ALS-TDP.
Llibre-Guerra JJ; Lee SE; Suemoto CK; Ehrenberg AJ; Kovacs GG; Karydas A; Staffaroni A; Franca Resende EP; Kim EJ; Hwang JH; Ramos EM; Wojta KJ; Pasquini L; Pang SY; Spina S; Allen IE; Kramer J; Miller BL; Seeley WW; Grinberg LT
Brain Pathol; 2021 Mar; 31(2):267-282. PubMed ID: 33314436
[TBL] [Abstract][Full Text] [Related]
15. Lack of a protective effect of the Tmem106b "protective SNP" in the Grn knockout mouse model for frontotemporal lobar degeneration.
Cabron AS; Borgmeyer U; Richter J; Peisker H; Gutbrod K; Dörmann P; Capell A; Damme M
Acta Neuropathol Commun; 2023 Jan; 11(1):21. PubMed ID: 36707901
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of TMEM106B C-terminal fragments in neurodegenerative disease and aging.
Perneel J; Neumann M; Heeman B; Cheung S; Van den Broeck M; Wynants S; Baker M; Vicente CT; Faura J; Rademakers R; Mackenzie IRA
Acta Neuropathol; 2023 Mar; 145(3):285-302. PubMed ID: 36527486
[TBL] [Abstract][Full Text] [Related]
17. Loss of TMEM106B leads to myelination deficits: implications for frontotemporal dementia treatment strategies.
Zhou X; Nicholson AM; Ren Y; Brooks M; Jiang P; Zuberi A; Phuoc HN; Perkerson RB; Matchett B; Parsons TM; Finch NA; Lin W; Qiao W; Castanedes-Casey M; Phillips V; Librero AL; Asmann Y; Bu G; Murray ME; Lutz C; Dickson DW; Rademakers R
Brain; 2020 Jun; 143(6):1905-1919. PubMed ID: 32504082
[TBL] [Abstract][Full Text] [Related]
18. Defining the association of TMEM106B variants among frontotemporal lobar degeneration patients with GRN mutations and C9orf72 repeat expansions.
Lattante S; Le Ber I; Galimberti D; Serpente M; Rivaud-Péchoux S; Camuzat A; Clot F; Fenoglio C; ; Scarpini E; Brice A; Kabashi E
Neurobiol Aging; 2014 Nov; 35(11):2658.e1-2658.e5. PubMed ID: 25085782
[TBL] [Abstract][Full Text] [Related]
19. Identification of TMEM106B amyloid fibrils provides an updated view of TMEM106B biology in health and disease.
Perneel J; Rademakers R
Acta Neuropathol; 2022 Nov; 144(5):807-819. PubMed ID: 36056242
[TBL] [Abstract][Full Text] [Related]
20. Loss of TMEM106B Ameliorates Lysosomal and Frontotemporal Dementia-Related Phenotypes in Progranulin-Deficient Mice.
Klein ZA; Takahashi H; Ma M; Stagi M; Zhou M; Lam TT; Strittmatter SM
Neuron; 2017 Jul; 95(2):281-296.e6. PubMed ID: 28728022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
